Back to News
investment
Takeda’s AI-Developed Psoriasis Pill Succeeds in Clinical Trials
Bloomberg
Loading...
1 min read
1 views
0 likes
Summarize this article with:
Takeda Pharmaceutical Co. announced that its oral psoriasis drug zasocitinib proved safe and effective in late-stage trials, marking a milestone in its effort to treat the incurable skin condition and offset looming revenue pressure.
Source Information
Source: Bloomberg